Presepsin Values Evaluated as Sepsis Severity Markers
|
By LabMedica International staff writers Posted on 23 Jun 2020 |

Image: Presepsin concentrations (ng/mL) in two severity groups. Black line: sepsis patients; black dotted line: septic shock patients (Photo courtesy of University Hospital for Infectious Diseases in Zagreb).
Sepsis is a life-threatening condition, with poor and highly variable clinical manifestations, difficult to identify and diagnose. Sepsis has remained a real diagnostic challenge to clinicians, causing millions of death worldwide each year. Early recognition of sepsis is crucial for better disease outcome.
Blood cultures are a gold standard for diagnosing sepsis. Despite the great advantages, blood cultures also have some limitations as they are often negative, especially in patients previously treated with antibiotic, and their results are usually obtained over several days. While waiting for blood culture results, treatment of critically ill septic patients may be delayed, increasing the possibility of poor outcome.
Infectious disease specialist at the University Hospital for Infectious Diseases (Zagreb, Croatia) and their colleagues conducted a prospective observational study in two university clinical centers and enrolled 100 septic patients during two time periods. New Sepsis-3 definitions were used for sepsis stratification. Biomarkers and SOFA score were evaluated four times during the illness.
Routine laboratory parameters and C-reactive protein (CRP) were tested immediately. For procalcitonin (PCT) and presepsin levels measurements, blood was collected at all four time points, frozen until the end of the study, and then measured. Quantitative analysis of PCT was performed using an automated electrochemiluminescence immunoanalyzer (ELECSYS* BRAHMS* PCT; Roche Diagnostics, Mannheim, Germany). A sandwich enzyme-linked immune-sorbent assay ̶ Human Presepsin ELISA Kit (Nordic Biosite, Täby, Sweden), was used for presepsin measurement.
The following laboratory parameters were recorded: red blood cell count, hemoglobin, hematocrit, white blood cell count, platelet count, serum creatinine, serum total bilirubin, serum liver enzymes (aspartate aminotransferase-AST and alanine aminotransferase-ALT), partial thromboplastin time (PTT), international normalized ratio (INR), electrolytes (sodium and potassium), blood gas analysis, CRP, PCT, and presepsin concentrations.
The scientists reported that presepsin concentrations were significantly higher on admission in 34 patients with septic shock compared to 66 patients with sepsis, mean ± SD: 128.5 ± 47.6 ng/mL versus 88.6 ± 65.6 ng/mL, respectively. The same was not observed for PCT and CRP; their concentrations did not differ significantly between severity groups. A strong correlation of presepsin with SOFA score was also found.
The authors concluded that their study showed that serum presepsin concentration on admission reflects the severity of disease. Presepsin was a better predictor of multiple organ dysfunction syndrome compared to other tested sepsis biomarkers. The strong correlation of presepsin with SOFA score makes this marker a valuable tool for identifying septic patients. PCT and CRP concentrations did not differ between sepsis severity groups. The study was published in the June, 2020 issue of the International Journal of Infectious Diseases.
Blood cultures are a gold standard for diagnosing sepsis. Despite the great advantages, blood cultures also have some limitations as they are often negative, especially in patients previously treated with antibiotic, and their results are usually obtained over several days. While waiting for blood culture results, treatment of critically ill septic patients may be delayed, increasing the possibility of poor outcome.
Infectious disease specialist at the University Hospital for Infectious Diseases (Zagreb, Croatia) and their colleagues conducted a prospective observational study in two university clinical centers and enrolled 100 septic patients during two time periods. New Sepsis-3 definitions were used for sepsis stratification. Biomarkers and SOFA score were evaluated four times during the illness.
Routine laboratory parameters and C-reactive protein (CRP) were tested immediately. For procalcitonin (PCT) and presepsin levels measurements, blood was collected at all four time points, frozen until the end of the study, and then measured. Quantitative analysis of PCT was performed using an automated electrochemiluminescence immunoanalyzer (ELECSYS* BRAHMS* PCT; Roche Diagnostics, Mannheim, Germany). A sandwich enzyme-linked immune-sorbent assay ̶ Human Presepsin ELISA Kit (Nordic Biosite, Täby, Sweden), was used for presepsin measurement.
The following laboratory parameters were recorded: red blood cell count, hemoglobin, hematocrit, white blood cell count, platelet count, serum creatinine, serum total bilirubin, serum liver enzymes (aspartate aminotransferase-AST and alanine aminotransferase-ALT), partial thromboplastin time (PTT), international normalized ratio (INR), electrolytes (sodium and potassium), blood gas analysis, CRP, PCT, and presepsin concentrations.
The scientists reported that presepsin concentrations were significantly higher on admission in 34 patients with septic shock compared to 66 patients with sepsis, mean ± SD: 128.5 ± 47.6 ng/mL versus 88.6 ± 65.6 ng/mL, respectively. The same was not observed for PCT and CRP; their concentrations did not differ significantly between severity groups. A strong correlation of presepsin with SOFA score was also found.
The authors concluded that their study showed that serum presepsin concentration on admission reflects the severity of disease. Presepsin was a better predictor of multiple organ dysfunction syndrome compared to other tested sepsis biomarkers. The strong correlation of presepsin with SOFA score makes this marker a valuable tool for identifying septic patients. PCT and CRP concentrations did not differ between sepsis severity groups. The study was published in the June, 2020 issue of the International Journal of Infectious Diseases.
Latest Microbiology News
- CE-Marked Blood Assay Automates Tuberculosis Infection Testing
- Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants
- Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
- H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
- Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
- Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
- Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
- Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
- Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
- New Protein Targets Support Diagnostics for Louse-Borne Relapsing Fever
- TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
- Automated Blood Culture System Speeds Detection of Bloodstream Infections
- New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
- Gut Microbiome Signatures Help Identify Risk of IBD Progression
- FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
- New AMR Assay Supports Rapid Infection Control Screening in Hospitals
Channels
Molecular Diagnostics
view channel
Epigenetic Profiling Could Refine Prognosis in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with heterogeneous biology that complicates prognostication and treatment selection. Genetic testing clarifies many drivers, yet it... Read more
Genetic Risk Score Supports Diagnosis and Prognosis in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) causes progressive, irreversible lung scarring that limits breathing and can lead to death. More than 100,000 Americans live with IPF, and an estimated 30,000–40,000... Read more
Extracellular Vesicle Marker Identifies Early Lung Adenocarcinoma and Predicts Recurrence
Lung cancer remains a leading cause of cancer death, and early-stage disease often produces few symptoms, complicating timely diagnosis and risk stratification. Conventional imaging and tissue biopsy have... Read moreHematology
view channel
New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more
AI Decision Support System Guides Treatment Selection for Complex Blood Cancers
Treatment selection for hematologic malignancies often requires clinicians to synthesize clinical histories, genomic alterations, prior therapies, and rapidly evolving drug options. These complex decisions... Read moreImmunology
view channel
Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19
Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more
Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms
Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read more
Emergency Department Opt-Out Testing Program Identifies Undiagnosed HIV
Undiagnosed HIV continues to drive avoidable morbidity and transmission, with many people identified only after substantial immune damage has occurred. In England, about one in 20 people living with HIV... Read more
Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission
Severe traumatic injury can trigger immune and organ dysfunction that complicates recovery in the intensive care unit. A subset of patients develop chronic critical illness, defined as dependence on intensive... Read moreMicrobiology
view channel
CE-Marked Blood Assay Automates Tuberculosis Infection Testing
Tuberculosis continues to pose a major global health challenge, with an estimated 10.7 million people falling ill and 1.23 million deaths in 2024. Roughly one quarter of the world’s population is believed... Read more
Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants
Genomic surveillance is essential for detecting viral variants before they spread widely, yet many public health systems face high costs, uneven capacity, and computational barriers. Existing analytic... Read more
Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
Acute infectious gastroenteritis remains a major cause of illness worldwide, especially in young children, older adults, and immunocompromised patients. Nonspecific symptoms such as diarrhea, vomiting,... Read more
H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read morePathology
view channel
New AI Test Delivers Rapid Breast Cancer Recurrence Predictions
Recurrent breast cancer remains a persistent driver of morbidity and retreatment, and current risk stratification often depends on genomic assays that are costly and slow. Waiting weeks for results can... Read more
EBV Status Helps Predict Survival in Primary CNS Lymphoma
Primary central nervous system lymphoma is a rare malignancy in which tumors arise in the brain and, less often, the spinal cord, eyes, or cerebrospinal fluid. Outcomes are especially variable when the... Read moreTechnology
view channel
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing
Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Eurobio Scientific Completes Acquisition of CareDx Lab Products Division
Eurobio Scientific has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitute CareDx’s Lab Products division. The business will... Read more
Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia
Colombia remains a high-priority setting for tuberculosis, with a growing need for diagnostics that complement existing testing strategies and improve access to earlier diagnosis. Solutions that function... Read more








